MSU
CELG

Maple Securities USA’s Celgene Corp CELG Stock Holding History

Maple Securities USA’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-3,949
Closed -$457K – 225
2015
Q2 		$457K Buy
+3,949
New +$451K 0.04% 126
2015
Q1 		– Sell
-11,362
Closed -$1.27M – 300
2014
Q4 		$1.27M Buy
11,362
+5,387
+90% +$568K 0.1% 60
2014
Q3 		$566K Buy
+5,975
New +$539K 0.06% 125
2014
Q2 		– Sell
-7,606
Closed -$531K – 315
2014
Q1 		$531K Buy
+7,606
New +$602K 0.05% 74
2013
Q3 		– Sell
-4,904
Closed -$287K – 584
2013
Q2 		$287K Buy
+4,904
New +$295K 0.03% 350

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Maple Securities USA's CELG Position: Q3 2015 in Review

Maple Securities USA sold out of Celgene Corp (CELG) in Q3 2015, closing a stake of 3,949 shares — an estimated $457K sold.

Maple Securities USA first reported a position in CELG in Q2 2013 and held it in 5 quarters. The position peaked at $1.27M in Q4 2014. 1,195 funds tracked by Wall St. Rank hold CELG as of Q3 2015.

  • Maple Securities USA reported no remaining Celgene Corp position as of Q3 2015 after selling out during the quarter.
  • Maple Securities USA sold 3,949 Celgene Corp shares in Q3 2015, an estimated $457K.
  • Maple Securities USA first reported a position in Celgene Corp in Q2 2013 and held it in 5 quarters.
  • Maple Securities USA's Celgene Corp position peaked at $1.27M in Q4 2014.
  • 1,195 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2015.

Based on Maple Securities USA's 13F filing for Q3 2015, filed 3 Nov 2015.